Over 1,100 peer-reviewed studies now document the anti-cancer potential of safe, non-toxic natural compounds:
This enourmous body of evidence underscores the urgent need to rigorously investigate non-toxic therapies as viable anti-cancer agents.
A peer-reviewed study in Oncotarget has documented one of the most extraordinary findings in natural-compound cancer research: an aqueous extract of dandelion root -- the common backyard plant -- reduced human colon tumor growth in mice by more than 90%, showed zero toxicity after 75 days of daily administration, and selectively killed cancer cells while sparing normal cells entirely.
Dandelion root also destroyed more than 95% of colon cancer cells in vitro and activated multiple programmed-cell-death pathways simultaneously. No synthetic chemotherapy drug achieves all of these effects at once -- which is why this study deserves far more attention than it received.
In immunocompromised CD-1 mice implanted with two different human colon cancer lines (HT-29 and HCT116), oral dandelion root extract at 40 mg/kg/day dramatically suppressed tumor growth.
The treatment "retarded the growth of human colon xenograft models by more than 90%."
Figure 4 from the paper shows the difference visually: control mice developed massive tumors, while DRE-treated mice barely formed any tumor mass at all. Even late in the 75-day study, tumor volumes remained extremely small.
Before testing tumor effects, researchers conducted a long-term toxicity assessment for 75 days at 40mg/kg/day:
In other words: DRE produced no observable harm, even with long-term systemic exposure -- a sharp contrast to standard chemotherapy, which can cause multi-organ toxicity at far lower exposure durations.